468 related articles for article (PubMed ID: 29638080)
1. ADVERSE DRUG REPORTING IN COMMUNITY PHARMACY PRACTICE IN THE POMERANIAN DISTRICT IN POLAND.
Zimmermann A; Gaworska-Krzeminska A; Flis A
Acta Pol Pharm; 2016 Sep; 73(5):1389-1396. PubMed ID: 29638080
[TBL] [Abstract][Full Text] [Related]
2. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
[TBL] [Abstract][Full Text] [Related]
3. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
Hajj A; Hallit S; Ramia E; Salameh P;
Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
[TBL] [Abstract][Full Text] [Related]
4. Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana'a, Yemen.
Al-Worafi YM; Kassab YW; Alseragi WM; Almutairi MS; Ahmed A; Ming LC; Alkhoshaiban AS; Hadi MA
Ther Clin Risk Manag; 2017; 13():1175-1181. PubMed ID: 28924350
[TBL] [Abstract][Full Text] [Related]
5. Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh.
Amin MN; Khan TM; Dewan SM; Islam MS; Moghal MR; Ming LC
BMJ Open; 2016 Aug; 6(8):e010912. PubMed ID: 27489151
[TBL] [Abstract][Full Text] [Related]
6. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
Li R; Curtain C; Bereznicki L; Zaidi STR
Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
[TBL] [Abstract][Full Text] [Related]
7. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
[No Abstract] [Full Text] [Related]
8. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul.
Toklu HZ; Uysal MK
Pharm World Sci; 2008 Oct; 30(5):556-62. PubMed ID: 18350373
[TBL] [Abstract][Full Text] [Related]
9. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
Su C; Ji H; Su Y
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
[TBL] [Abstract][Full Text] [Related]
10. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
[TBL] [Abstract][Full Text] [Related]
11. Medication safety knowledge, attitude, and practice among hospital pharmacists in Lebanon.
Hallit S; Hajj A; Shuhaiber P; Iskandar K; Ramia E; Sacre H; Salameh P;
J Eval Clin Pract; 2019 Apr; 25(2):323-339. PubMed ID: 30592116
[TBL] [Abstract][Full Text] [Related]
12. The role of hospital and community pharmacists in pharmacovigilance.
van Grootheest AC; de Jong-van den Berg LT
Res Social Adm Pharm; 2005 Mar; 1(1):126-33. PubMed ID: 17138470
[TBL] [Abstract][Full Text] [Related]
13. Adverse drug reactions reporting: pharmacists' knowledge, attitude and practice in Shiraz, Iran.
Afifi S; Maharloui N; Peymani P; Namazi S; Gharaei AG; Jahani P; Lankarani KB
Int J Risk Saf Med; 2014; 26(3):139-45. PubMed ID: 25214159
[TBL] [Abstract][Full Text] [Related]
14. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.
Dorji C; Tragulpiankit P; Riewpaiboon A; Tobgay T
Drug Saf; 2016 Dec; 39(12):1239-1250. PubMed ID: 27743333
[TBL] [Abstract][Full Text] [Related]
15. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
[TBL] [Abstract][Full Text] [Related]
17. Exploring factors underlying the attitude of community pharmacists to generic substitution: a nationwide study from Poland.
Drozdowska A; Hermanowski T
Int J Clin Pharm; 2016 Feb; 38(1):162-70. PubMed ID: 26620450
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
19. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
[TBL] [Abstract][Full Text] [Related]
20. Detection of adverse drug reactions among ordinary users of liraglutide on the occasion of drug dispensing in the community pharmacy setting.
Christensen ST; Bjerrum OJ
J Patient Saf; 2013 Dec; 9(4):219-23. PubMed ID: 24257065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
